Clinically significant estimated glomerular filtration rate decline is common in patients receiving immune checkpoint inhibitors: implications for long-term cancer survivors

Donald F. Chute, Sophia Zhao, Ian A. Strohbehn, Nifasha Rusimbayala, Harish Seethapathy, Meghan Lee, Leyre Zubiri, Shruti Gupta, David E. Leaf, Osama Rahma, Zsofia D. Drobni, Tomas G. Neilan, Kerry L. Reynolds, Meghan E. Sise
doi: https://doi.org/10.1101/2020.12.18.20248471

Data Availability

De-identified data can be made available upon request.

Back to top
Posted December 22, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Clinically significant estimated glomerular filtration rate decline is common in patients receiving immune checkpoint inhibitors: implications for long-term cancer survivors
Donald F. Chute, Sophia Zhao, Ian A. Strohbehn, Nifasha Rusimbayala, Harish Seethapathy, Meghan Lee, Leyre Zubiri, Shruti Gupta, David E. Leaf, Osama Rahma, Zsofia D. Drobni, Tomas G. Neilan, Kerry L. Reynolds, Meghan E. Sise
medRxiv 2020.12.18.20248471; doi: https://doi.org/10.1101/2020.12.18.20248471
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools

Subject Area